BioAge Labs, Inc. × Age Labs AS
BioAge Labs announced a collaboration with Norwegian diagnostics company Age Labs AS to profile and analyze over 17,000 samples from the HUNT Biobank. [39, 40] The initiative will generate millions of molecular readouts from samples collected over decades, and BioAge has secured exclusive access to this data for its drug discovery platform focused on aging. [39, 44] Financial terms of the collaboration were not disclosed. [41]
The asset
Exclusive access for drug discovery to molecular data generated from profiling over 17,000 samples from the HUNT Biobank in Norway.
- 17k individual samples
- 6k participants
The record
- Seller status
- Going concern
- Sector
- Diagnostics
- Modalities
- proteomic data, clinical data, biospecimens
- Jurisdiction
- NO
What it means if you hold data
This partnership provides a blueprint for biotechs to access deeply characterized longitudinal data from large, population-based biobanks. It highlights the value of multi-omic data linked to long-term health outcomes for identifying novel therapeutic targets related to aging and chronic disease. [39, 44]